Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma
- 30 November 2013
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 34 (34), 8718-8725
- https://doi.org/10.1016/j.biomaterials.2013.07.068
Abstract
No abstract availableKeywords
Funding Information
- Alberta Cancer Foundation
- Canadian Institute of Health Research
- NIH COBRE grant (1P20RR024219-01A2)
- Intramural Research Program of the NIH
This publication has 47 references indexed in Scilit:
- SGN-30: a basis for the effective treatment of CD30 positive hematopoietic malignanciesExpert Opinion on Investigational Drugs, 2008
- Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cellsExperimental Cell Research, 2008
- Disposition of Drugs in Block Copolymer Micelle Delivery SystemsClinical Pharmacokinetics, 2008
- A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated ratsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal ModelsCancer Research, 2006
- Establishment and Evaluation of Cancer-Specific Human Monoclonal Antibody GAH for Targeting Chemotherapy Using ImmunoliposomesHybridoma and Hybridomics, 2004
- CD30-mediated cell cycle arrest associated with induced expression of p21CIP1/WAF1 in the anaplastic large cell lymphoma cell line Karpas 299Oncogene, 2001
- Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal TissuesJapanese Journal of Cancer Research, 1998
- Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's SarcomaThe Journal of Clinical Pharmacology, 1996
- Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cellsNature, 1982